1.Treatment outcome of status epilepticus in Thammasat University Hospital, Thailand
Kongkiat Kulkantrakorn ; Weraphan Moonman
Neurology Asia 2014;19(1):257-262
Background and Objective: Status epilepticus (SE) is an emergency condition with high mortality rate,
particularly in patients whose treatment is delayed. This is to describe clinical characteristics, treatment
process, and outcome and to determine clinical parameters which impact the SE outcome. Methods: This
was a descriptive study in 60 SE patients admitted between 2004-2011 to the Thammasat University
Hospital, Pathumthani, Thailand. The correlation between the outcome and clinical parameters was
analyzed. Results: Sixty SE patients were included (38 men; 22 women), mean age 55 years. Generalized
convulsive status epilepticus was the most common (55 events, 91.6%). Forty-three patients (71.7%)
had previous diagnosis of neurological disorders. AED withdrawal and old ischemic stroke were the
common causes of SE. The mean time from onset to treatment was 163.4 minutes and door to needle
time was 19.8 minutes. Diazepam and phenytoin were most commonly used as first and second line
AED. Eight patients (13%) developed refractory SE. The mortality rate was 25%, with 28.3% in total
dependent state, 20% had incomplete recovery, and 26.7% had complete recovery. The risk factors
which correlated with death were old age, long duration of seizure and coma.
Conclusion: In this cohort from north Bangkok and central Thailand, the mortality and morbidity rates
were high. More efforts should be taken to address the long delay to treatment, and other correctable
factors.
2.Treatment outcome of status epilepticus in Thammasat University Hospital, Thailand
Kongkiat Kulkantrakorn ; Weraphan Moonman
Neurology Asia 2014;19(3):257-262
Background and Objective: Status epilepticus (SE) is an emergency condition with high mortality rate, particularly in patients whose treatment is delayed. This is to describe clinical characteristics, treatment process, and outcome and to determine clinical parameters which impact the SE outcome. Methods: This was a descriptive study in 60 SE patients admitted between 2004-2011 to the Thammasat University Hospital, Pathumthani, Thailand. The correlation between the outcome and clinical parameters was analyzed. Results: Sixty SE patients were included (38 men; 22 women), mean age 55 years. Generalized convulsive status epilepticus was the most common (55 events, 91.6%). Forty-three patients (71.7%) had previous diagnosis of neurological disorders. AED withdrawal and old ischemic stroke were the common causes of SE. The mean time from onset to treatment was 163.4 minutes and door to needle time was 19.8 minutes. Diazepam and phenytoin were most commonly used as first and second line AED. Eight patients (13%) developed refractory SE. The mortality rate was 25%, with 28.3% in total dependent state, 20% had incomplete recovery, and 26.7% had complete recovery. The risk factors which correlated with death were old age, long duration of seizure and coma. Conclusion: In this cohort from north Bangkok and central Thailand, the mortality and morbidity rates were high. More efforts should be taken to address the long delay to treatment, and other correctable factors.
3.Non-motor symptoms in Thai Parkinson’s disease patients: Prevalence, manifestation and health related quality of life
Praween Lolekha ; Kongkiat Kulkantrakorn
Neurology Asia 2014;19(2):163-170
Background & Objective: Non-Motor Symptoms (NMS) are common in Parkinson’s disease (PD). While prevalence of each NMS in Thai PD patients is unknown, these NMS might have an impact on patients’ wellbeing. The aim of this study is to identify the prevalence, pattern and impact of NMS on the quality of life in Thai PD patients. Methods: A cross-sectional study in 115 PD patients was conducted at Thammasat University hospital. Subtype of PD, Schwab & England activity of daily living (ADL scale), Unified Parkinson’s Disease Rating Scale (UPDRS) motor score and the modified Hoehn & Yahr (H&Y scale) were recorded. NMS and quality of life were assessed using Thammasat University Non-Motor Symptoms Questionnaire (TU-NMSQuest) and Parkinson’s Disease Questionnaire-8 (PDQ-8). Results: All patients reported at least one NMS. A mean number of 15.94 ± 6.48 NMS was reported by each patient. Nocturia (79.1%), urinary urgency (73%), and fatigue (71.3%) were the most prevalent NMS. Significant correlations were observed between TU-NMSQuest and UPDRS motor score, H&Y scale, ADL scale, subtype of PD, and PDQ-8. Conclusion: NMS are common and have a significant impact on the quality of life in PD patients. Advanced disease stage, poorer motor or ADL function, and non-tremor dominant subtype are associated with a higher number of NMS and lower quality of life in Thai PD patients.
4.Emerging concepts and treatment in neuropathic pain
Neurology Asia 2012;17(4):265-271
Knowledge in neuropathic pain has grown rapidly during the past few years. Central and peripheral
sensitization is still believed to be the main pathophysiology. New evidence suggests many potential
new molecular targets and mechanisms, such as cytokines, lysophosphatidic acid and ion channels.
Microglia and astrocyte activation leads to dysregulation of infl ammatory cytokines and pain signaling.
Many subtypes of the sodium channel have been shown to be the culprit for both congenital and
acquired pain syndromes, especially small fi ber neuropathy. Lysophosphatidic acid is thought to act
as an initiator of neuropathic pain, along with other mediators. Animal models of neurodegenerative
diseases and chemotherapy-induced neuropathy reaffi rm the role of nociceptor degeneration and
cytoskeletal breakdown in peripheral neuropathy. With better understanding of its mechanism, it may
lead to new therapeutic targets. Recent trials of new medications, new formulations or new indication
of old drugs have shown promising data. We can look forward to better treatment of this debilitating
symptom in the near future.
5.Heroin brachial plexopathy
Neurology Asia 2011;16(1):85-87
Neuromuscular complications from heroin abuse are rare. Most cases are caused by focal nerve
compression and recover spontaneously. We report a 22-year-old Caucasian man who presented with
shoulder pain and left arm weakness after recovering from coma due to heroin and phenobarbitone
overdose. Electrophysiological fi ndings were consistent with complete brachial plexopathy. Investigations
did not reveal any other causes. Follow up examination at 4 weeks showed minimal improvement
of his weakness. This case highlights an unusual complication of heroin abuse. Its pathophysiology
remains unknown. Although heroin abuse is now less common, neurologists should be aware of this
condition
Result Analysis
Print
Save
E-mail